IGC Pharma's total assets for Q1 2025 were $10.59M, a decrease of -5.91% from the previous quarter. IGC total liabilities were $2.71M for the fiscal quarter, a 23.03% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.